Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Rezolute, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q4 2021
- Shares held
- 7.09M
- −444.0K (−5.9%) vs. Q4 2021
- Total value
- $24.0M
- −$12.0M (−33.4%) vs. Q4 2021
- New holders
- 4
- 7 more added
- Sold out
- 6
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RZLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 144 | $450.3M |
| Q1 2026 | 125 | $263.2M |
| Q4 2025 | 122 | $213.4M |
| Q3 2025 | 116 | $817.1M |
| Q2 2025 | 92 | $347.5M |
| Q1 2025 | 77 | $130.6M |
| Q4 2024 | 71 | $211.7M |
| Q3 2024 | 59 | $186.9M |
| Q2 2024 | 52 | $170.0M |
| Q1 2024 | 33 | $69.0M |
| Q4 2023 | 32 | $28.7M |
| Q3 2023 | 30 | $31.5M |
| Q2 2023 | 29 | $48.0M |
| Q1 2023 | 32 | $46.5M |
| Q4 2022 | 34 | $50.6M |
| Q3 2022 | 33 | $67.0M |
| Q2 2022 | 35 | $79.2M |
| Q1 2022 | 21 | $24.0M |
| Q4 2021 | 23 | $36.0M |
| Q3 2021 | 14 | $17.6M |
| Q2 2021 | 12 | $31.6M |
| Q1 2021 | 11 | $17.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Rezolute, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 3,189,222 | $10.8M | 0.02% | 00.0% | Unchanged |
| Caxton Corp | 1,193,473 | $4.03M | 5.02% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 748,702 | $2.53M | 1.05% | −59,703−7.4% | Reduced |
| AIGH Capital Management LLC | 420,913 | $1.42M | 0.52% | +155,732+58.7% | Added |
| Vanguard Group Inc | 343,739 | $1.16M | 0.00% | +10,500+3.2% | Added |
| Citadel Advisors LLC | 327,953 | $1.11M | 0.00% | +19,666+6.4% | Added |
| Velan Capital Investment Management LP | 300,000 | $1.01M | 0.94% | 00.0% | Unchanged |
| BVF Inc | 190,815 | $645.0K | 0.03% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 104,709 | $354.0K | 0.17% | +43,991+72.5% | Added |
| Geode Capital Management, LLC | 68,989 | $233.0K | 0.00% | +68,989 | New |
| J. Goldman & Co LP | 54,000 | $183.0K | 0.01% | −148,500−73.3% | Reduced |
| Northern Trust Corp | 51,516 | $174.0K | 0.00% | −777−1.5% | Reduced |
| Boothbay Fund Management, LLC | 24,000 | $81.0K | 0.00% | −12,922−35.0% | Reduced |
| BlackRock Inc. | 21,528 | $72.0K | 0.00% | +1,945+9.9% | Added |
| State Street Corp | 20,300 | $69.0K | 0.00% | +20,300 | New |
| Provence Wealth Management Group | 20,000 | $68.0K | 0.08% | +20,000 | New |
| UBS Group AG | 4,491 | $15.0K | 0.00% | +183+4.2% | Added |
| The PNC Financial Services Group, Inc. | 750 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 610 | $2.00K | 0.00% | +610 | New |
| Wells Fargo & Company | 72 | $0 | 0.00% | +1+1.4% | Added |
| Morgan Stanley | 21 | $0 | 0.00% | 00.0% | Unchanged |
| Altium Capital Management LP | 0 | $0 | 0.00% | −230,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −115,758−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −104,053−100.0% | Sold out |
| Sender Co & Partners, Inc. | 0 | $0 | 0.00% | −81,849−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −20,571−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −11,780−100.0% | Sold out |